Nguyen, Thanh Liem https://orcid.org/0000-0002-4036-0161
Nguyen, Hoang Phuong
Ngo, Duy Minh
Ha, Thu Hien Thi
Mai, Kieu - Anh
Bui, Thu Hang
Nguyen, Phan Van
Pham, Lan Huong
Hoang, Duc Minh
Cao, Anh Dao Thi
Article History
Received: 8 September 2021
Accepted: 1 February 2022
First Online: 14 March 2022
Declarations
:
: The study protocol was reviewed and approved by the Institutional Review Board of Vinmec International Hospital on January 15, 2017. The reference number for the ethics approval is 150117/2017/QD-VMEC. The committee evaluated the ethical aspects of the study in accordance with the World Medical Association’s Declaration of Helsinki. The study was explained in detail to the parents of the participants.
: This manuscript does not include personal information of participants. Therefore, written inform consent for publication is not applicable. We confirm that informed consent to receive the cell therapy/interventions containing explanation of benefits and risks was obtained from parent of all patients. Autologous BMMNC infusion for children with BA was approved by the Ministry of Health (Approval number: 612/QD-BYT). Participants in this study did pay for treatment fee.
: The authors have declared that no competing interests exist.